Mayo Clinic labs in Rochester begin monkeypox testing
ROCHESTER, Minn. (WKBT) — Mayo Clinic Laboratories will begin testing for monkeypox Monday using CDC’s orthopoxvirus test, which detects most non-smallpox related orthopoxviruses, including monkeypox.
Mayo Clinic Laboratories will offer this testing at its Mayo Clinic’s Division of Clinical Microbiology laboratories in Rochester and can accept specimens from anywhere in the country. Mayo Clinic Laboratories expects to be able to perform up to 10,000 tests per week, which will continue to increase the current capacity provided through CDC’s Laboratory Response Network (LRN) and Labcorp, which began testing last week.
“The ability of commercial laboratories to test for monkeypox is an important pillar in our comprehensive strategy to combat this disease,” said CDC Director Rochelle Walensky. “This will not only increase testing capacity but also make it more convenient for providers and patients to access tests by using existing provider-to-laboratory networks.”
Anyone with a rash that looks like monkeypox should talk to their healthcare provider about whether they need to get tested, even if they don’t think they had contact with someone who has monkeypox. Healthcare providers nationwide can order the orthopoxvirus test from Mayo Clinic Laboratories just as they normally would order other tests. The public will not be able to go to a Mayo Clinic laboratory and submit a specimen.
Mayo Clinic Laboratories will use electronic laboratory reporting to report results to jurisdictions as outlined in the CDC reporting guidance.
Recent News Headlines from News 8 Now
Sparta Police form relationships with families through sports cards pastime
Grills and campfire can be cause of preventable injuries, UW Health warns
Blue Stars bring Drum and Bugle Corps from around Midwest to La Crosse for River City Rhapsody
Information session coming for Civil Air Patrol Cadet Program in La Crosse
Anthony’s Day celebrates life of La Crosse man
COPYRIGHT 2022 BY NEWS 8 NOW/NEWS 8000. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.
